Role of Glutathione in the Multidrug Resistance in Cancer

[1] ADLER V, YIN Z, FUCHS SY, BENEZRA M, ROSARIO L, TEW KD, PINCUS MR, SARDANA M, HENDERSON CJ, WOLF CR, DAVIS RJ, RONAI Z. Regulation of JNK signaling by GSTp. Embo J 1999; 18: 1321-1334.10.1093/emboj/18.5.1321Open DOISearch in Google Scholar

[2] ARRIGO AP. Gene expression and the thiol redox state. Free Radic Biol Med 1999; 27(9-10): 936-944.10.1016/S0891-5849(99)00175-6Search in Google Scholar

[3] BAILEY HH. L-S,R-buthionine sulfoximine: historical development and clinical issues. Chem Biol Interact 1998; 111-112: 239-254.10.1016/S0009-2797(97)00164-6Search in Google Scholar

[4] BALLATORI N, KRANCE SM, MARCHAN R, HAMMOND CL. Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology. Mol Aspects Med 2009; 30(1-2): 13-28.10.1016/j.mam.2008.08.00418786560Open DOISearch in Google Scholar

[5] BALLATORI N, REBBEOR JF. Roles of MRP2 and oatp1 in hepatocellular export of reduced glutathione. Semin Liver Dis 1998; 18(4): 377-387.10.1055/s-2007-10071719875555Open DOISearch in Google Scholar

[6] BILSKA A, KRAWCZYK A, WŁODEK L. Różne oblicza biologicznej roli glutationu. Postepy Hig Med Dosw 2007; 61: 438-453.Search in Google Scholar

[7] BODA D, NÉMETH I, PINTÉR S. Surface tension, glutathione content and redox ratio of the tracheal aspirate fluid of premature infants with IRDS. Biol Neonate. 1998; 74(4): 281-288.970165010.1159/000014035Search in Google Scholar

[8] BORST P, EVERS R, KOOL M, WIJNHOLDS J.The multidrug resistance protein family. Biochim Biophys Acta 1999; 1461(2): 347-357.10.1016/S0005-2736(99)00167-4Search in Google Scholar

[9] CAI J, JONES DP. Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss. J Biol Chem 1998; 273(19): 11401-11404.10.1074/jbc.273.19.11401Search in Google Scholar

[10] COLE SP, DEELEY RG. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP. Bioessays 1998; 20(11): 931-940.987205910.1002/(SICI)1521-1878(199811)20:11<931::AID-BIES8>3.0.CO;2-JSearch in Google Scholar

[11] COLE SPC, BHARDWAJ G, GERLACH JH, MACKIE JE, GRANT CE, ALMQUIST KC, STEWART AJ, KURZ EU, DUNCAN AMV, DEELEY RG. Overexpression of a transporter gene in a multidrugresistant human lung cancer cell line. Science 1992; 258: 1650-1654.10.1126/science.1360704Search in Google Scholar

[12] DAUBEUF S, LEROY P, PAOLICCHI A, POMPELLA A, WELLMAN M, GALTEAU MM, VISVIKIS A. Enhanced resistance of HeLa cells to cisplatin by overexpression of γ-glutamyltransferase. Biochem Pharmacol 2002; 64 (2): 207-216.10.1016/S0006-2952(02)01118-812123741Open DOISearch in Google Scholar

[13] DEELEY RG, COLE SP. Substrate recognition and transport by multidrug resistance protein 1 (ABCC1). FEBS Lett 2006; 580(4): 1103-1111.10.1016/j.febslet.2005.12.036Search in Google Scholar

[14] DEMASI M, SHRINGARPURE R, DAVIES KJ. Glutathiolation of the proteasome is enhanced by proteolytic inhibitors. Arch Biochem Biophys 2001; 389(2): 254-63.10.1006/abbi.2001.2332Search in Google Scholar

[15] DOROSHOW JH, AKMAN S, CHU FF, ESWORTHY S. Role of the glutathione-glutathione peroxidase cycle in the cytotoxicity of the anticancer quinones. Pharmacol Ther 1990; 47(3): 359-367.229085310.1016/0163-7258(90)90062-7Search in Google Scholar

[16] EATON DL, HAMEL DM. Increase in gamma-glutamylcysteine synthetase activity as a mechanism for butylated hydroxyanisole-mediated elevation of hepatic glutathione. Toxicol Appl Pharmacol 1994; 126(1): 145-149.10.1006/taap.1994.11007910419Open DOISearch in Google Scholar

[17] FOJO T, BATES S. Strategies for reversing drug resistance. Oncogene 2003; 22(47): 7512-7523.1457685510.1038/sj.onc.1206951Search in Google Scholar

[18] GARTENHAUS RB, PRACHAND SN, PANIAQUA M, LI Y, GORDON LI. Arsenic trioxide cytotoxicity in steroid and chemotherapy-resistant myeloma cell lines: enhancement of apoptosis by manipulation of cellular redox state. Clin Cancer Res 2002; 8(2): 566-72.11839678Search in Google Scholar

[19] GATÉ L, PAUL J, BA GN, TEW KD, TAPIERO H. Oxidative stress induced in pathologies: the role of antioxidants. Biomed Pharmacother 1999; 53(4): 169-180.1039228910.1016/S0753-3322(99)80086-9Search in Google Scholar

[20] GENDŹWIŁŁ A. Reaktywne formy tlenu i hiporeaktywność naczyń we wstrząsie septycznym. Część II - Przeciwutleniacze i hiporeaktywność naczyń we wstrząsie septycznym. Pol Merk Lek 2007; XXIII(136): 284-287.Search in Google Scholar

[21] HIPFNER DR, DEELEY RG, COLE SP. Structural, mechanistic and clinical aspects of MRP1. Biochim Biophys Acta 1999; 1461(2): 359-376.10.1016/S0005-2736(99)00168-6Search in Google Scholar

[22] HWANG C, SINSKEY AJ, LODISH HF. Oxidized redox state of glutathione in the endoplasmic reticulum. Science 1992; 257( 5076): 1496-1502.10.1126/science.1523409Search in Google Scholar

[23] JULIANO RL, LING VA. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976; 455: 152-162.10.1016/0005-2736(76)90160-7Search in Google Scholar

[24] KLATT P, LAMAS S. Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. Eur J Biochem 2000; 267(16): 4928-4944.10.1046/j.1432-1327.2000.01601.xSearch in Google Scholar

[25] KLEE S, NÜRNBERGER MC, UNGEMACH FR. The consequences of nitrofurantoin-induced oxidative stress in isolated rat hepatocytes: evaluation of pathobiochemical alterations. Chem Biol Interact 1994; 93(2): 91-102. 808223510.1016/0009-2797(94)90089-2Search in Google Scholar

[26] KOOL M, VAB DER LINDEN M, DE HAAS M, SCHEFFER GL, DE VREE JM, SMITH AJ, JANSEN G, PETERS GJ, PONNE N, SCHEPER RJ, ELFERINK RP, BAAS F, BORST P. MRP3, an organic anion transporter able to transport anti-cancer drugs. Natl Acad Sci U S A 1999; 96(12): 6914-9619.10.1073/pnas.96.12.69142201610359813Open DOISearch in Google Scholar

[27] KRUH GD, BERLINSKY MGThe MRP family of drug efflux pumps. Oncogene 2003; 22: 7537-7552.10.1038/sj.onc.120695314576857Open DOISearch in Google Scholar

[28] LAI GM, MOSCOW JA, ALVAREZ MG, FOJO AT, BATES SF. Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines. Int J Cancer 1991; 49(5): 688-695.10.1002/ijc.291049051116822791682279Open DOISearch in Google Scholar

[29] LEWIS AD, HAYES JD, WOLF CR. Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effects. Carcinogenesis 1988; 9(7): 1283-1287.289830610.1093/carcin/9.7.12832898306Search in Google Scholar

[30] LOE DW, DEELEY RG, COLE SP. Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione. Cancer Res 1998; 58(22): 5130-5136.Search in Google Scholar

[31] LOE DW, OLESCHUK CJ, DEELEY RG, COLE SP. Structure-activity studies of verapamil analogs that modulate transport of leukotriene C(4) and reduced glutathione by multidrug resistance protein MRP1. Biochem Biophys Res Commun 2000; 275(3): 795-803.10.1006/bbrc.2000.338410973801Search in Google Scholar

[32] LORICO A, BERTOLA A, BAUM C, FODSTAD O, RAPPA G. Role of the Multidrug Resistance Protein 1 in protection from heavy metal oxyanions: investigations in vitro and in MRP1-deficient mice. Biochem Biophys Res Commun 2002; 291(3): 617-622.10.1006/bbrc.2002.648911855834Search in Google Scholar

[33] ŁUKASZEWICZ-HUSSAIN A. Rola glutationu i enzymów z nim związanych w procesach antyoksydacyjnych organizmu. Med Pr 2003; 54(5): 473-479.Search in Google Scholar

[34] MANNA SK, KUO MT, AGGARWAL BB. Overexpression of gamma-glutamylcysteine synthetase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1. Oncogene 1999; 18(30): 4371-4382.10.1038/sj.onc.120281110439045Search in Google Scholar

[35] MEIJERMAN I, BEIJNEN JH, SCHELLENS JHM. Combined action and regulation of phase II enzymes and multidrug resistance proteins in multidrug resistance in cancer. Cancer treatment reviews 2008; 34(6): 505-520.10.1016/j.ctrv.2008.03.0021841328118413281Open DOISearch in Google Scholar

[36] MEISTER A, ANDERSON ME. Glutathione. Annu Rev Biochem 1983; 52: 711-760.10.1146/annurev.bi.52.070183.0034316137189Open DOISearch in Google Scholar

[37] MEURETTE O, LEFEUVRE-ORFILA L, REBILLARD A, LAGADIC-GOSSMANN D, DIMANCHEBOITREL MT. Role of intracellular glutathione in cell sensitivity to the apoptosis induced by tumor necrosis factor {alpha}-related apoptosis-inducing ligand/anticancer drug combinations. Clin Cancer Res 2005; 11(8): 3075-3083.10.1158/1078-0432.CCR-04-1764Open DOISearch in Google Scholar

[38] MORAN LK, GUTTERIDGE JM, QUINLAN GJ. Thiols in cellular redox signalling and control. Curr Med Chem 2001; 8(7): 763-772.10.2174/0929867013372904Open DOISearch in Google Scholar

[39] MULLER M, MEUER C, ZAMAN GJR, BORST P, SCHEPER RJ,MULDER NH, DE VRIES EGE, JANSEN PLM. Overexpression of the gene encoding the multidrug Resistanceassociated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci USA 1994; 91: 13033-13037.10.1073/pnas.91.26.13033Open DOISearch in Google Scholar

[40] O'BRIEN M, KRUH GD, TEW KD. The influence of coordinate overexpression of glutathione phase II detoxification gene products on drug resistance. J Pharmacol Exp Ther 2000; 294(2): 480-487.Search in Google Scholar

[41] OGUCHI H, KIKKAWA F, KOJIMA M, MAEDA O, MIZUNO K, SUGANUMA N, KAWAI M, TOMODA Y. Glutathione related enzymes in cis-diamminedichloroplatinum (II)-sensitive and-resistant human ovarian carcinoma cells. Anticancer Res 1994;14(1A): 193-200.7909418Search in Google Scholar

[42] OHD JF, NIELSEN CK, CAMPBELL J, LANDBERG G, LÖFBERG H, SJÖLANDER A. Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas. Gastroenterology 2003; 124(1): 57-70.1251203010.1053/gast.2003.50011Search in Google Scholar

[43] OZOLS RF, LOUIE KG, PLOWMAN J, BEHRENS BC, FINE RL, DYKES D, HAMILTON TC. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione. Biochem Pharmacol 1987; 36(1): 147-153. 10.1016/0006-2952(87)90392-33801051Open DOISearch in Google Scholar

[44] PALMER HJ, PAULSON KE. Reactive oxygen species and antioxidants in signal transduction and gene expression. Nutr Rev 1997; 55: 353-361.935407910.1111/j.1753-4887.1997.tb01561.xSearch in Google Scholar

[45] PAOLICCHI A, LORENZINI E, PEREGO P, SUPINO R, ZUNINO F, COMPORTI M, POMPELLA A. Extra-cellular thiol metabolism in clones of human metastatic melanoma with different gamma-glutamyl transpeptidase expression: implications for cell response to platinum-based drugs. Int J Cancer 2002; 97(6): 740-745.10.1002/ijc.10110Open DOISearch in Google Scholar

[46] PAULUSMA CC, VAN GEER MA, EVERS R, HEIJN M, OTTENHOFF R, BORST P, OUDE ELFERINK RP. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J 1999; 338(Pt 2): 393-401.10.1042/bj3380393Search in Google Scholar

[47] PAYEN L, COURTOIS A, VERNHET L, GUILLOUZO A, FARDEL O. The multidrug resistanceassociated protein (MRP) is over-expressed and functional in rat hepatoma cells. Int J Cancer 1999; 81(3): 479-485.10.1002/(SICI)1097-0215(19990505)81:3<479::AID-IJC24>3.0.CO;2-SOpen DOISearch in Google Scholar

[48] POMPELLA A, DE TATA V, PAOLICCHI A, ZUNINO F. Expression of gamma-glutamyltransferase in cancer cells and its significance in drug resistance. Biochem Pharmacol 2006; 71(3): 231-238.10.1016/j.bcp.2005.10.00516303117Open DOISearch in Google Scholar

[49] PRIEBE W, KRAWCZYK M, KUO MT, YAMANE Y, SAVARAJ N, ISHIKAWA T. Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump. Biochem Biophys Res Commun 1998; 247(3): 859-863.10.1006/bbrc.1998.8887Search in Google Scholar

[50] REBBEOR JF, CONNOLLY GC, HENSON JH, BOYER JL, BALLATORI N. ATP-dependent GSH and glutathione S-conjugate transport in skate liver: role of an Mrp functional homologue. Am J Physiol Gastrointest Liver Physiol 2000; 279(2): G417-G425.10.1152/ajpgi.2000.279.2.G417Search in Google Scholar

[51] REED JC. Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. Semin Hematol 1997; 34(4 Suppl 5): 9-19.9408956Search in Google Scholar

[52] RISTOFF E, LARSSON A. Inborn errors in the metabolism of glutathione. Orphanet J Rare Dis 2007; 2: 16-24.10.1186/1750-1172-2-16Open DOISearch in Google Scholar

[53] RODRIGUEZ JF, CORDERO J, CHANTRY C, GONZÁLEZ S, RIVERA C, FEBO I, COLÓN A, DÍAZ C. Plasma glutathione concentrations in children infected with human immunodeficiency virus. Pediatr Infect Dis J. 1998; 17(3): 236-241.10.1097/00006454-199803000-000129535252Open DOISearch in Google Scholar

[54] SALERNO M, LOECHARIYAKUL P, SAENGKHAE C, GARNIER-SUILLEROT A. Relation between the ability of some compounds to modulate the MRP1-mediated efflux of glutathione and to inhibit the MRPl-mediated efflux of daunorubicin. Biochem Pharmacol 2004; 68(11): 2159-2165.10.1016/j.bcp.2004.08.010Open DOISearch in Google Scholar

[55] SCHNEIDER E, HORTON J, YANG CH, NAKAGAWA M, COWAN KH. Multidrug resistanceassociated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF-7 cell line selected for etoposide resistance. Cancer Res 1994; 54: 152-158.Search in Google Scholar

[56] SCHULZ JB, LINDENAU J, SEYFRIED J, DICHGANS J. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 2000; 267(16): 4904-4911.10.1046/j.1432-1327.2000.01595.xSearch in Google Scholar

[57] SEN CK, PACKER L. Antioxidant and redox regulation of gene transcription. FASEB-J 1996; 10(7): 709-72010.1096/fasebj.10.7.8635688Search in Google Scholar

[58] TANIGUCHI M, YASUTAKE A, TAKEDOMI K, INOUE K. Effects of N-nitrosodimethylamine (NDMA) on the oxidative status of rat liver. Arch Toxicol 1999; 73(3):141-146.10.1007/s002040050598Open DOISearch in Google Scholar

[59] TEODORI E, DEI S, SCAPECCHI S, GUALTIERI F. The medicinal chemistry of multidrug resistance (MDR) reversing drugs. Il Farmaco 2002; 57(5): 385-41510.1016/S0014-827X(02)01229-6Open DOISearch in Google Scholar

[60] TEW KD. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 1994; 54: 4313-4320.8044778Search in Google Scholar

[61] TIPNIS SR, BLAKE DG, SHEPHERD AG, MCLELLAN LI. Overexpression of the regulatory subunit of gamma-glutamylcysteine synthetase in HeLa cells increases gamma-glutamylcysteine synthetase activity and confers drug resistance. Biochem J 1999; 337(Pt 3): 559-566.10.1042/bj3370559Search in Google Scholar

[62] TOWNSEND DM, TEW KD. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 2003; 22(47): 7369-7375.10.1038/sj.onc.120694014576844Open DOISearch in Google Scholar

[63] VAHRMEIJER AL, HOETELMANS RW, MULDER GJ, SCHUTRUPS J, VAN VLIERBERGHE RL, VAN DE VELDE CJ, VAN DIERENDONCK JH. Development of resistance to glutathione depletion induced cell death in CC531 colon carcinoma cells: association with increased expression of bcl-2. Biochem Pharmacol 2000; 59(12): 1557-1562.10.1016/S0006-2952(00)00286-0Open DOISearch in Google Scholar

[64] VAN BLADEREN PJ. Glutathione conjugation as a bioactivation reaction. Chem Biol Interact 2000; 129: 61-76.10.1016/S0009-2797(00)00214-3Search in Google Scholar

[65] VERSANTVOORT CH, BROXTERMAN HJ, BAGRIJ T, SCHEPER RJ, TWENTYMAN PR. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. Br J Cancer 1995; 72(1): 82-89.10.1038/bjc.1995.28120341637599070Open DOISearch in Google Scholar

[66] YOSHIDA A, TAKEMURA H, INOUE H, MIYASHITA T, UEDA T. Inhibition of glutathione synthesis overcomes Bcl-2-mediated topoisomerase inhibitor resistance and induces nonapoptotic cell death via mitochondrial-independent pathway. Cancer Res 2006; 66(11): 5772-5780.10.1158/0008-5472.CAN-05-39161674071616740716Open DOISearch in Google Scholar

[67] YOUNG LC, CAMPLING BG, VOSKOGLOU-NOMIKOS T, COLE SP, DEELEY RG, GERLACH JH. Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response. Clin Cancer Res 1999 Mar; 5(3): 673-680.Search in Google Scholar

[68] ZAMAN GJ, LANKELMA J, VAN TELLINGEN O, BEIJNEN J, DEKKER H, PAULUSMA C, OUDE ELFERINK RP, BAAS F, BORST P. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci U S A 1995; 92(17): 7690-7694.10.1073/pnas.92.17.7690412117644478Open DOISearch in Google Scholar

[69] ZEMBROŃ-ŁACNY A., SZYSZKA K., SOBAŃSKA B., PAKUŁA R. Przemiana glutationu we krwi biegaczy średniodystansowych. Borgis - Nowa Medycyna, 1999; 7: 20-22. Search in Google Scholar